Greater Trochanteric Bursa Injections After Total Hip Arthroplasty
Yes, greater trochanteric bursa injections can be safely performed after total hip arthroplasty and are an effective first-line treatment for post-operative trochanteric bursitis, with 74-80% of patients responding to conservative management including corticosteroid injections. 1, 2
Clinical Context and Safety
Greater trochanteric pain syndrome (trochanteric bursitis) is a common complication following total hip arthroplasty, occurring in approximately 4.6-6.1% of patients regardless of surgical approach. 1, 2 The key safety consideration is distinguishing this extra-articular soft tissue pathology from intra-articular prosthetic joint infection (PJI), as the guidelines emphasize caution with injections in the presence of prosthetic joints. 3
The critical distinction is that trochanteric bursa injections are extra-articular (outside the joint capsule), whereas the infection risk concerns in the guidelines primarily relate to intra-articular injections near prosthetic implants. 4, 3
Diagnostic Approach
Clinical Diagnosis
- Physical examination with palpation over the greater trochanter is the primary diagnostic method used by most surgeons. 5
- Pain localized to the lateral hip that does not involve the hip joint itself distinguishes this from intra-articular pathology. 5
Imaging Guidance
- Ultrasound is the preferred imaging modality for both diagnosis and injection guidance, as it can evaluate superficial structures like the abductor tendons and trochanteric bursa without ionizing radiation. 4
- Fluoroscopic guidance improves accuracy significantly—blind injections achieve correct bursal placement only 45% of the time on first attempt, compared to higher success rates with imaging. 6
- MRI can identify associated pathology including abductor tendinosis, tears, or calcific tendonitis when diagnosis is uncertain. 4
Treatment Algorithm
First-Line Management
- Oral anti-inflammatory medications (used by 57.1% of surgeons as initial therapy). 5
- Structured physiotherapy (52.4% of surgeons). 5
- Image-guided corticosteroid injection into the greater trochanteric bursa (45.2% of surgeons, 74-80% effective). 1, 2, 5
Injection Technique Specifics
- Target the greater trochanteric bursa specifically rather than the subgluteus medius bursa—injections into the greater trochanteric bursa provide significantly better pain reduction (median reduction of 3 points vs 0 points on visual analog scale, p<0.01). 7
- Use ultrasound or fluoroscopic guidance to ensure accurate needle placement, as blind injections frequently miss the target. 6, 8
- Inject a 3-mL corticosteroid solution under direct imaging guidance. 7
Expected Outcomes
- 80% of patients achieve symptom resolution with conservative management including injections. 2
- 45% of patients require multiple injections for complete resolution. 2
- Younger patients and those with significant leg-length discrepancy may be more likely to fail nonoperative treatment. 2
Risk Factors for Post-THA Trochanteric Bursitis
History of preoperative corticosteroid injection is the strongest predictor of requiring postoperative injections (adjusted odds ratio 3.772, p<0.001). 9
Additional risk factors include:
- Female sex (stronger risk factor than surgical approach). 9
- Posterior surgical approach (11.5% incidence vs 7.3% with anterior approach, adjusted odds ratio 1.242, p=0.001). 9
- History of smoking. 1
- Lumbar spinal stenosis. 1
Critical Pitfalls to Avoid
- Do not confuse extra-articular trochanteric bursa injections with intra-articular hip joint injections—the infection risk profile differs substantially, and trochanteric injections do not violate the prosthetic joint space. 4, 3
- Avoid blind injections without imaging guidance, as accuracy is poor (only 45% correct placement on first attempt). 6
- Do not inject the subgluteus medius bursa when targeting trochanteric bursitis—this location is significantly less effective. 7
- Consider that up to one-third of patients may fail initial conservative therapy and require multiple treatment modalities. 5